56 related articles for article (PubMed ID: 3580508)
41. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma.
Battayani Z; Grob JJ; Xerri L; Noe C; Zarour H; Houvaeneghel G; Delpero JR; Birmbaum D; Hassoun J; Bonerandi JJ
Arch Dermatol; 1995 Apr; 131(4):443-7. PubMed ID: 7726587
[TBL] [Abstract][Full Text] [Related]
42. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
[TBL] [Abstract][Full Text] [Related]
43. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
44. Immunomodulation by bacterial fractions.
Barot-Ciorbaru R
Int J Immunopharmacol; 1994; 16(5-6):469-73. PubMed ID: 7927995
[TBL] [Abstract][Full Text] [Related]
45. An original method for submacroscopic metastases visualization in cases of cancer minimal residual disease.
Le Pape A; Barot-Ciorbaru R; Musset M; Baulieu JL; Jubault C; Lemarié E; Pourcelot L; Besnard JC; Nicolau C; Mathé G
Biomed Pharmacother; 1986; 40(10):392-8. PubMed ID: 3580508
[TBL] [Abstract][Full Text] [Related]
46. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
47. Detection of occult melanoma cells in sentinel lymph nodes and blood.
Reintgen DS; Conrad AJ
Semin Oncol; 1997 Feb; 24(1 Suppl 4):S11-5. PubMed ID: 9122728
[TBL] [Abstract][Full Text] [Related]
48. Management of melanoma metastasis to the breast: case series and review of the literature.
Loffeld A; Marsden JR
Br J Dermatol; 2005 Jun; 152(6):1206-10. PubMed ID: 15948983
[TBL] [Abstract][Full Text] [Related]
49. Molecular staging for melanoma and breast cancer.
Shivers SC; Stall A; Goscin C; Trudeau W; Li W; Haddad FF; Reintgen DS
Surg Oncol Clin N Am; 1999 Jul; 8(3):515-26. PubMed ID: 10448694
[TBL] [Abstract][Full Text] [Related]
50. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
